Form 4: GoodRx Holdings Chief Accounting Officer Romin Nabiey Reports New Stock Options and Restricted Stock Units
SEC Form 4 Filing
Romin Nabiey, Chief Accounting Officer of GoodRx Holdings, reports the acquisition of stock options and restricted stock units.
Summary
- On March 5, 2025, Romin Nabiey, the Chief Accounting Officer of GoodRx Holdings, Inc., reported transactions related to the company's stock.
- Nabiey acquired 76,866 restricted stock units (RSUs) and 114,507 stock options.
- The RSUs vest as to 6.25% on May 15, 2025, and the remaining 93.75% vest in approximately equal quarterly installments over the following 15 quarters.
- The stock options, with an exercise price of $4.94, also vest as to 6.25% on May 15, 2025, with the remaining 93.75% vesting in approximately equal quarterly installments over the following 15 quarters.
- Following these transactions, Nabiey directly owns 99,439 shares of Class A Common Stock, 76,866 restricted stock units, and 114,507 stock options.
Sentiment
Score: 7
Explanation: The sentiment is neutral to slightly positive. It reflects standard executive compensation practices and insider ownership transparency. The granting of equity can be seen as a positive sign of aligning management interests with shareholders.
Positives
- The granting of RSUs and stock options to the Chief Accounting Officer aligns their interests with the long-term performance of the company.
- The vesting schedule encourages continued service and commitment from the executive.
Industry Context
Form 4 filings are standard practice for reporting changes in beneficial ownership by company insiders, providing transparency to investors.
Comparison to Industry Standards
- Granting stock options and restricted stock units to executives is a common practice in the tech industry to incentivize performance and align interests with shareholders.
- Vesting schedules similar to the one described (quarterly installments over several years) are typical for executive compensation packages.
Stakeholder Impact
- Shareholders may view the granting of stock options and RSUs as a positive sign, aligning management's interests with the company's long-term success.
- Employees may see this as a standard practice for executive compensation.
Key Dates
| Date | Description |
|---|---|
| 03/05/2025 | Date of the reported transactions: acquisition of restricted stock units and stock options. |
| 03/07/2025 | Date of the Form 4 filing. |
| 05/15/2025 | Initial vesting date for 6.25% of the restricted stock units and stock options. |
| 03/05/2035 | Expiration date of the stock options. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.